Image For Activity Cover
The Connection Between Mental Health and Opioid Use Disorder
Overview



Presenter(s):
 Mark Duncan, MD, Assistant Professor, University of Washington, Director, UW Psychiatry and Addictions Case Conference


Target Audience: This activity is designed for physicians, nurse practitioners or other advanced practice nurses, PAs, social workers, pharmacists, and healthcare teams. This activity is accredited for physicians, nurse practitioners or other advanced practice nurses, PAs, social workers, pharmacists, and healthcare teams.

Credit designations available: AMA PRA Category 1 Credit™, AAPA Category 1 CME, Social Work CE Credit, Nursing Contact Hours, Pharmacy CE Credit, Interprofessional Continuing Education (IPCE) Credit.

Webinar Description: There is a high prevalence of mental health disorders among those with opioid use disorder. However, many practitioners still find it difficult to distinguish between differential diagnoses that may have similar symptomatology, especially in regards to mental health and substance misuse. This webinar will enable participants to summarize the prevalence of common co-morbid mental illness, explain the relationships between concurrent mental health and opioid use disorder (OUD) and recognize risk factors associated with both mental health disorders and OUD.

Educational Objectives:

  • Summarize the prevalence of common co-morbid mental health (MH) disorders.
  • Explain genetic and environmental relationship between concurrent MH disorders and Opioid Use Disorder (OUD).
  • Describe the impact that co-occurring MH and OUD can have on treatment of both.
Summary
Availability: On-Demand
Expires on Feb 03, 2026
Cost: FREE
Credit Offered:
1 CME Credit
1 PA-CME Credit
1 Other Professionals Credit
1 Social Work (ACE) Credit
1 Nursing Credit
1 Pharmacy Credit
1 IPCE Credit
Recommended
 
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.



Funding for this initiative was made possible (in part) by grant nos. 1H79TI086770 and 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

 
PCSS-MOUD
PCSS-MOUD.org
pcss@aaap.org
For Buprenorphine Training Inquiries, email PCSS-MOUD.

ORN
opioidresponsenetwork.org

Powered By